Cargando…
Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial
BACKGROUND: Left ventricular dysfunction and the development of heart failure is a frequent and serious complication of myocardial infarction. Recent animal experimental studies suggested that metformin treatment reduces myocardial injury and preserves cardiac function in non-diabetic rats after exp...
Autores principales: | Lexis, Chris P. H., van der Horst, Iwan C. C., Lipsic, Erik, van der Harst, Pim, van der Horst-Schrivers, Anouk N. A., Wolffenbuttel, Bruce H. R., de Boer, Rudolf A., van Rossum, Albert C., van Veldhuisen, Dirk J., de Smet, Bart J. G. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464381/ https://www.ncbi.nlm.nih.gov/pubmed/22968678 http://dx.doi.org/10.1007/s10557-012-6413-1 |
Ejemplares similares
-
Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial
por: Haver, Vincent G., et al.
Publicado: (2015) -
The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial
por: Lexis, Chris P H, et al.
Publicado: (2015) -
Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial
por: Eppinga, Ruben N., et al.
Publicado: (2016) -
Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT
por: Hartman, Minke H. T., et al.
Publicado: (2017) -
Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial
por: Posma, Rene A., et al.
Publicado: (2015)